LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 658 | 1198 | 3761 | 0.3185 | 0.2689 |
Hs 578T | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 658 | 1208 | 3761 | 0.3212 | 0.2728 |
Hs 578T | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 658 | 1163 | 3761 | 0.3092 | 0.2538 |
Hs 578T | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1129 | 3761 | 0.3002 | 0.2390 |
Hs 578T | WYE-125132 | 10 | uM | LJP6 | 72 | hr | 658 | 1014 | 3761 | 0.2698 | 0.1877 |
Hs 578T | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 658 | 1259 | 3933 | 0.3203 | 0.2862 |
Hs 578T | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 658 | 1213 | 3933 | 0.3086 | 0.2676 |
Hs 578T | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 658 | 1162 | 3933 | 0.2953 | 0.2460 |
Hs 578T | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 658 | 1217 | 3933 | 0.3095 | 0.2691 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 658 | 1155 | 3933 | 0.2936 | 0.2436 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 72 | hr | 658 | 938 | 3933 | 0.2386 | 0.1474 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 658 | 4080 | 3933 | 1.0374 | 1.0286 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 658 | 4031 | 3933 | 1.0248 | 1.0190 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3892 | 3933 | 0.9895 | 0.9917 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3708 | 3933 | 0.9429 | 0.9549 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3040 | 3933 | 0.7729 | 0.8097 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 658 | 1915 | 3933 | 0.4870 | 0.5130 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 658 | 4173 | 3933 | 1.0610 | 1.0463 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 658 | 3975 | 3933 | 1.0107 | 1.0082 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 658 | 4046 | 3933 | 1.0285 | 1.0218 |
Hs 578T | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 658 | 4153 | 3933 | 1.0560 | 1.0426 |
Hs 578T | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 658 | 4086 | 3933 | 1.0389 | 1.0297 |
Hs 578T | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 658 | 3433 | 3933 | 0.8728 | 0.8971 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 658 | 2361 | 3761 | 0.6280 | 0.6621 |
Hs 578T | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 658 | 2070 | 3761 | 0.5502 | 0.5768 |